Skip to content

SI-BONE, Inc. SIBN Preferred Stock, Shares Authorized

Preferred Stock, Shares Authorized at other companies

IAR
Integra LifeSciencesIART
Bioventus logo
BioventusBVS
3D Systems logo
3D SystemsDDD
Intuitive Surgical logo
Intuitive SurgicalISRG

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%
EPS (diluted)-$0.10+33.3%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
Operating cash flow-$2.4M+51.9%
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$743.29M+6.4%
Enterprise value$752.71M+8.4%
P/S3.6×-0.4×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.

The official record: SI-BONE, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about SI-BONE, Inc.'s preferred stock, shares authorized.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SI-BONE, Inc.'s preferred stock, shares authorized?
SI-BONE, Inc. (SIBN) reported preferred stock, shares authorized of $5M in Q1 2026.
How has SI-BONE, Inc.'s preferred stock, shares authorized changed year-over-year?
SI-BONE, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
What is the long-term trend for SI-BONE, Inc.'s preferred stock, shares authorized?
Over 5 years (2020 to 2025), SI-BONE, Inc.'s preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.